Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | Secondary analysis of SELECT2: cerebral edema in large ischemic core after thrombectomy

Felix Ng, MBBS, BMedSc, DCH, MPH, FRACP, University of Melbourne, Melbourne, Australia, discusses a secondary analysis of the SELECT2 trial (NCT03876457) investigating cerebral edema in patients with large ischemic core strokes undergoing thrombectomy. Prof. Ng highlights the higher incidence of cerebral edema observed in the thrombectomy cohort and emphasizes the importance of closely monitoring these patients for signs of cerebral edema following thrombectomy. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

So cerebral edema in ischemic stroke is part of the natural history, and it can be fatal. It has a high mortality. Most of the time, we know that reperfusion in a timely manner will reduce cerebral edema. However, there’s particular concerns that if someone presents at baseline with a large core already, that you reperfuse the core, it would actually exacerbate the edema. And that originates from earlier animal studies that show that if you have transient MCA occlusion, the cerebral edema actually increases and there’s larger infarct as well...

So cerebral edema in ischemic stroke is part of the natural history, and it can be fatal. It has a high mortality. Most of the time, we know that reperfusion in a timely manner will reduce cerebral edema. However, there’s particular concerns that if someone presents at baseline with a large core already, that you reperfuse the core, it would actually exacerbate the edema. And that originates from earlier animal studies that show that if you have transient MCA occlusion, the cerebral edema actually increases and there’s larger infarct as well. So the particular concerns, of course, is if someone comes in who has large core already, the clinical guidelines at the moment and the evidence supports that we should be doing thrombectomy. However, a portion of such patients will be more susceptible to developing cerebral edema. So the SELECT2 trial is a large-core trial that looked at whether thrombectomy compared to standard care for patients presenting with a large-core defined by ASPECTS 3 to 5 or at least a core volume of 50, whether thrombectomy would be beneficial. It was a positive trial that showed thrombectomy is associated with better functional outcome in such large core patients. We performed a secondary analysis focusing on edema development in these patients. And what we found that was that cerebral edema was higher in the thrombectomy cohort. So that means patients who had thrombectomy of a large core are more prone to cerebral edema. It would reduce slightly the benefits of thrombectomy. However, that doesn’t necessarily mean that we should withhold thrombectomy because overall on a population level, at a group study level, patients who have large core still derive benefits from thrombectomy even though there was a higher chance of cerebral edema developing. And what the secondary analysis conveys is that when we do thrombectomy on large-core patients, we should be more careful about cerebral edema developing in patients, and we should make preparatory steps. So, for example, we should talk in advance with the patient when they consent that this might be happening so that they have an informed consent, informed opinion when they decide on whether to have thrombectomy or not or have any other treatment. And once thrombectomy has occurred, then there should be more intense monitoring. That might be the form of an early CT that looks at whether there’s evolving edema several hours after thrombectomy and follow such patients on with more frequent serial CT so that if there’s early signs of edema, we are all ready to perform salvage or any treatment procedures such as decompressive craniotomy. And that also would mean a more frequent clinical monitoring, probably up to the first three to five days.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.